In conclusion, we have provided evidence that the HIF-1α inhibitor echinomycin reduces aGVHD without weakening GVL effect, which is associated with increased donor Treg development and reduced alloantigen-specific Th17 and Th1 responses in vivo, resulting in significantly prolonged leukemia free survival in mice. Here, HIF1A is linked to leukemia.